LP16328-4
Levodopa
Active
Description
The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. Source: National Library of Medicine, MeSH 2006
Basic Part Properties
- Part Display Name
- Levodopa
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2000-05-04
- Construct for LOINC Short Name
- L-Dopa
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP16328-4 - ConceptMap translate
- https:
//fhir.loinc.org/ConceptMap/$translate?system=http: //loinc.org&code=LP16328-4
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
zh-CN | Chinese (China) | 左旋多巴 Synonyms: L-多巴; |
fr-CA | French (Canada) | Lévodopa |
et-EE | Estonian (Estonia) | Levodopa |
es-ES | Spanish (Spain) | Levodopa |
it-IT | Italian (Italy) | Levodopa |
tr-TR | Turkish (Turkey) | Levodopa |
ru-RU | Russian (Russian Federation) | Леводопа |
nl-NL | Dutch (Netherlands) | levodopa |
fr-BE | French (Belgium) | Lévodopa |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright